Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.

SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.

SAN FRANCISCO—PSA doubling time (PSADT) is the most important predictor of 15-year overall survival among men who experience biochemical recurrence after radical prostatectomy for prostate cancer, according to a study.

Aspirin use is associated with lower PSA levels in men who have never smoked, data suggest.

SAN FRANCISCO—The prostate cancer gene 3 (PCA3) molecular urine test is more accurate than the PSA test in predicting outcomes of repeat biopsies, new findings confirm.

Onset of statin use is associated with a significant reduction in serum PSA level, data suggest.

A study of a large multiethnic cohort found that African-American men had a higher prevalence of PSA screening than white and Latino men.

After a median of 32 months, PSA was undetectable in 12% of patients.

The likelihood of an abnormal finding is 46% lower in obese men than normal-weight men, study shows

Positive margins at the prostate base are associated with the worst outcomes.